Milan Chheda is an Oncology physician affiliated with Washington University in St. Louis. OpenAlex indexes 144 publications with 7,668 citations (h-index 32); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4921 Parkview Pl
Div Im Medical Oncology, Ste 7a, 7b, 7c
Saint Louis, MO 631101032
Telephone
800-647-2098Registry record last updated 17 Apr 2025.
Clinical trials
- Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
Sponsor: Washington University School of Medicine
- Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
Sponsor: Washington University School of Medicine
- Asciminib With or Without Sildenafil for Brain Tumors
Sponsor: Washington University School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novocure Israel LtdProgram year20251 payment$105,000openpaymentsdata.cms.gov ↗
- Telix PharmaceuticalsProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
44.5%Corticosteroid44.5%Dexamethasone sodium phosphate86%Dexamethasone14%Part D + Part B≥22 patientsMetabolism & gastrointestinal
27.8%Serotonin-3 Receptor Antagonist27.8%Palonosetron hcl90%Ondansetron Hcl10%Part D + Part B≥16 patientsNervous system
23.7%Other antiepileptics10.4%Levetiracetam73%Lacosamide27%Part D<11 patientsCentral Nervous System Stimulant3%Methylphenidate Er100%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Expand and pull: long-acting IL-7 and oncolytic virus to treat glioblastoma
Washington University
FY2026$645,185R01CA305974 - Leveraging Zika virus and the immune system to treat glioblastoma
Washington University
FY2025$401,786R01NS117149 - Leveraging Zika virus and the immune system to treat glioblastoma
Washington University
FY2024$418,485R01NS117149
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma
International Journal of Radiation Oncology*Biology*Physics
2024 - Predicting post-surgical functional status in high-grade glioma with resting state fMRI and machine learning
Journal of Neuro-Oncology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Ley, MD
Washington University in St. Louis
David Gutmann, MD
Washington University in St. Louis
Randall Bateman, MD
Washington University in St. Louis
Victoria Fraser, MD
Washington University in St. Louis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”